drugset
drugset / Trial / NCT01271348

Study of Etoricoxib for the Treatment of Muscle Pain and Inflammation Induced by Eccentric Exercise

NCT01271348 ↗

Phase 1 Completed 50 enrolled X-pert Med GmbH
RandomizedCrossoverDouble-blindTreatment

Summary

Comparison of the effect of etoricoxib to placebo on muscle pain caused by eccentric contractions

Timeline

Start
2011-01
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etoricoxib Small molecule 90 mg —

Indications

No indication recorded.